101 related articles for article (PubMed ID: 10221179)
1. [The in vitro properties of a new hydroxypyridone antimycotic rilopirox, with special reference to its anti-Candida activity].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1999 Feb; 52(2):146-52. PubMed ID: 10221179
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1997 Feb; 50(2):195-9. PubMed ID: 9100079
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox.
Braga PC; Dal Sasso M; Maci S; Piatti G; Dannhorn DR; Bohn M
Arzneimittelforschung; 1995 Jan; 45(1):84-7. PubMed ID: 7893277
[TBL] [Abstract][Full Text] [Related]
4. Rilopirox--a new hydroxypyridone antifungal with fungicidal properties.
Raether W; Hänel H
Mycoses; 1990 Apr; 33(4):191-202. PubMed ID: 2233892
[TBL] [Abstract][Full Text] [Related]
5. Alterations in surface morphology of Candida albicans produced by rilopirox: a scanning electron microscopy study.
Braga PC; Maci S; Dal Sasso M; Piatti G; Bohn M
J Chemother; 1995 Dec; 7(6):519-24. PubMed ID: 8667036
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.
Sigle HC; Schäfer-Korting M; Korting HC; Hube B; Niewerth M
Mycoses; 2006 May; 49(3):159-68. PubMed ID: 16681805
[TBL] [Abstract][Full Text] [Related]
7. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
Braga PC; Maci S; Dal Sasso M; Bohn M
Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
[TBL] [Abstract][Full Text] [Related]
8. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of three topical antimycotics against ring-worm fungi singly and in combination.
Rai MK; Upadhyay SK; Agrawal SC
Hindustan Antibiot Bull; 1992; 34(3-4):104-7. PubMed ID: 1289296
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
11. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
12. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
13. [Action of isoconazole on Candida albicans. Study by scanning and transmission electron microscopy].
Moulin-Traffort J; Venot C; Regli P
Pathol Biol (Paris); 1986 Oct; 34(8):899-907. PubMed ID: 3537934
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox.
Reitze HK; Dannhorn DR; Hänel H; Seitz KA
Mycoses; 1993; 36(11-12):385-95. PubMed ID: 7935570
[TBL] [Abstract][Full Text] [Related]
15. [Various factors influencing in vitro antifungal activities of omoconazole nitrate (OMZ), a new imidazole antimycotic].
Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Jan; 47(1):40-9. PubMed ID: 8114272
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
Barug D; Bastiaanse HB
Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD
J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
[TBL] [Abstract][Full Text] [Related]
20. Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosis.
Beggs WH
Antimicrob Agents Chemother; 1984 Nov; 26(5):699-701. PubMed ID: 6097174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
